Meet Thomas Aloia, M.D.
Thomas A. Aloia, M.D., M.H.C.M., F.A.C.S.
Department of Surgical Oncology, Division of Surgery
Present Title & Affiliation
Primary Appointment
Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2019 | Harvard School of Public Health, Boston, MA, USA, MHCM, Master in Health Care Management |
| 2010 | Jessie H. Jones Graduate School of Business, Rice University, Houston, TX, USA, Certificate, Medical and Healthcare Management |
| 1996 | University of California-Los Angeles School of Medicine, Los Angeles, CA, USA, MD, Medicine |
| 1992 | Cornell University, Ithaca, NY, USA, BA, Biological Sciences |
Postgraduate Training
| 2015-2015 | 2nd Annual Clinical Trial Methods & Design Workshop for Junior Faculty, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2015-2015 | ACS Ultrasound for Surgeons Certification, National Ultrasound Foundation (NUF) Ultrasound in Surgery Instructor Certification, Houston, TX |
| 2015-2015 | 3rd Annual Mid-Career Academic Surgery Professional Development Course, Society of University Surgeons, Las Vegas, NV |
| 2013-2013 | Executive Education, Value Measurement in Health Care Course, Harvard Business School, Boston, MA |
| 2012-2020 | Basic Life Support Training, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2005-2006 | Clinical Fellowship, Liver Transplantation and Hepatobiliary Surgery, Paul Brousse Hospital, Villejuif |
| 2003-2005 | Clinical Fellowship, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2002-2003 | Chief Resident, General and Thoracic Surgery, Duke University Medical Center, Durham, NC |
| 2000-2002 | Clinical Residency, General and Thoracic Surgery, Duke University Medical Center, Durham, NC |
| 1998-2000 | Research Fellowship, Thoracic Oncology Laboratory, Duke University Medical Center, Durham, NC |
| 1997-1998 | Clinical Residency, General and Thoracic Surgery, Duke University Medical Center, Durham, NC |
| 1996-1997 | Clinical Internship, General and Thoracic Surgery, Duke University Medical Center, Durham, NC |
Board Certifications
| 2007 | Certificate in Surgical Oncology, Society of Surgical Oncology |
| 2004 | American Board of Surgery |
Experience & Service
Academic Appointments
Associate Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2019
Administrative Appointments/Responsibilities
Center Medical Director, Gastrointestinal Cancer Center, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2019
Executive Director of Cancer Network Quality, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - Present
Head, Institute for Cancer Center Innovation, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - Present
Division Quality Officer, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2018
Associate Head, Institute for Cancer Care Innovation, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2017
Director of Quality and Outcomes, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2018
Deputy Chair for Education, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2017
Program Director, International Surgical Oncology Fellowship Program, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - Present
Surgery Special Assistant for Quality, The University of Texas MD Anderson Cancer Center, Physicians Network, Houston, TX, 2014 - Present
Associate Medical Director, Gastrointestinal Cancer Center, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2018
Program Director, Hepato-Pancreato-Biliary Surgery Fellowship Program, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, 2012 - 2019
Surgeon Champion, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center NSQIP Program, Houston, TX, 2011 - Present
Institutional Committee Activities
Member, The University of Texas MD Anderson Cancer Center, Quality Operations Team, 2016 - 2018
Member, The University of Texas MD Anderson Cancer Center, Hospital Practice Committee, 2015 - 2018
Member, The University of Texas MD Anderson Cancer Center, Clinical Education Team, 2014 - 2018
Chair, The University of Texas MD Cancer Center, Graduate Medical Education Committee, Budget Subcommittee, 2014 - 2019
Member, The University of Texas MD Anderson Cancer Center, Graduate Medical Education Committee, Budget Subcommittee, 2013 - 2019
Chair, The University of Texas MD Anderson Cancer Center, Electronic Health Record (EHR) Value Measurement Committee, 2013 - 2017
Chair, The University of Texas MD Anderson Cancer Center, Division of Surgery Continuous Quality Improvement (CQI) Committee, 2013 - 2018
Member, Texas Medical Center, Surgical Quality Advisory Council, 2013 - Present
Member, The University of Texas MD Anderson Cancer Center, Innovative Clinical Care Committee, 2013 - Present
Member, The University of Texas MD Anderson Cancer Center, Medical Quality Planning Committee, 2013 - 2019
Chair, The University of Texas MD Anderson Cancer Center Department of Surgical Oncology Grand Rounds, 2012 - 2018
Member, The University of Texas MD Anderson Cancer Center Institutional GMEC Committee, 2012 - Present
Member, The University of Texas MD Anderson Cancer Center Medical Record Committee, 2012 - 2019
Physician Ambassador, The University of Texas MD Anderson Cancer Center, DoS Physician Executive Steering Committee, 2011 - Present
Member, The University of Texas MD Anderson Cancer Center Institutional Patient Safety Committee, 2011 - Present
Provider Ambassador, The University of Texas MD Anderson Cancer Center Physician Steering Committee for the Medicare Electronic Health Record, 2011 - 2018
Member, The University of Texas MD Anderson Cancer Center Infection Control Committee, 2011 - Present
Member, The University of Texas MD Anderson Cancer, Quality College Advisory Group, 2011 - Present
Honors & Awards
| 2018 | Emil J Freireich Award for Excellence in Education, The University of Texas MD Anderson Cancer Center Clinical Education Excellence Awards |
| 2018 | 2018 Top Performers, Clinician and Group Consumer Assessment of Helathcare Providers and Systems (CGCAHPS) |
| 2017 | Courtenay and R. William Bass Surgical Research Scholarship Mentor Award, Houston Methodist Hospital |
| 2017 | Highest Impact Speaker Award, The University of Texas MD Anderson Cancer Center, Graduate Medical Education (GME) Curriculum |
| 2016 | Graphic Design USA 2016 Health and Wellness Design Award, The University of Texas MD Anderson Cancer Center, Division of Surgery Surgical Outcomes |
| 2016 | Best Poster Award, Western Surgical Association |
| 2015 | Compagnons Hepato-Biliares, Honor Society, Paul Brousse Hospital Alumni |
| 2015 | President's Recognition for Faculty Excellence, The University of Texas MD Anderson Cancer Center |
| 2015 | Award for Best Poster Presentation, Western Surgical Association Annual Meeting |
| 2014 | President's Recognition for Faculty Excellence, The University of Texas MD Anderson Cancer Center |
| 2014 | Julie and Ben Rogers Award for Excellence in the Area of Patient Care, The University of Texas MD Anderson Cancer Center |
| 2013 | Executive of the Year, International Association of Administrative Professionals (IAAP) |
| 2013 | Radiological Society of North America Education Award, Radiological Society of North America |
| 2013 | President's Recognition for Faculty Excellence, The University of Texas MD Anderson Cancer Center |
| 2013 | Society for Surgery of the Alimentary Tract Best Article Award, Journal of Gastrointestinal Surgery |
| 2012 | Bayer HealthCare Pharmaceuticals, Inc. Mentor Award, The University of Texas MD Anderson Cancer Center |
| 2012 | North South Traveling Fellowship, Americas Hepato-Pancreato-Biliary Association |
| 2012 | J. Bradley Aust Award for Best New Member Paper, Western Surgical Association Annual Meeting |
| 2010 | Australia New Zealand Traveling Fellowship, American College of Surgeons |
| 2009 | Karen and Josef E. Fischer International Traveling Fellowship Award for Surgeons in Academic Practice, Society for Surgery of the Alimentary Tract |
| 2009 | Dyer and Baucum Health Quality Fellowship, The Methodist Hospital |
| 2005 | Surgical Oncology Fellowship Award for Excellence in Clinical Practice, The University of Texas MD Anderson Cancer Center |
| 2004 | Administrative Fellow in Surgical Oncology, The University of Texas MD Anderson Cancer Center |
| 2004 | Trainee Recognition Day Poster Award for Clinical Research, The University of Texas MD Anderson Cancer Center |
| 1999 | President's Award: Best Scientific Paper, Southern Thoracic Surgical Association |
| 1998 | Duke Comprehensive Cancer Center Harry Hutchison Gibson Fellow in Cancer Research, Duke University |
| 1995 | Alpha Omega Alpha, UCLA School of Medicine |
| 1992 | Graduation with Distinction in All Subjects, Cornell University |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Marcus RK, Lillemoe HA, Rice DC, Mena G, Bednarski BK, Speer BB, Ramirez PT, Lasala JD, Navai N, Williams WH, Kim BJ, Voss RK, Gottumukkala VN, Aloia TA. Determining the Safety and Efficacy of Enhanced Recovery Protocols in Major Oncologic Surgery: An Institutional NSQIP Analysis. Ann Surg Oncol 26(3):782-790, 2019. e-Pub 2019. PMID: 30627879.
- Yamashita S, Sheth RA, Niekamp AS, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C. Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status. Ann Surg 266(6):1045-1054, 2017. e-Pub 2016. PMID: 27735824.
- Yamashita S, Loyer E, Kang HC, Aloia TA, Chun YS, Mehran RJ, Eng C, Lee JE, Vauthey JN, Conrad C. Total Transthoracic Approach Facilitates Laparoscopic Hepatic Resection in Patients with Significant Prior Abdominal Surgery. Ann Surg Oncol 24(5):1376-1377, 2017. e-Pub 2016. PMID: 27878479.
- Yamashita S, Koay EJ, Passot G, Shroff R, Raghav KP, Conrad C, Chun YS, Aloia TA, Tao R, Kaseb A, Javle M, Crane CH, Vauthey JN. Local Therapy Reduces the Risk of Liver Failure and Improves Survival in Patients with Intrahepatic Cholangiocarcinoma: a Comprehensive Analysis of 362 Consecutive Patients. Cancer 123(8):1354-1362, 2017. e-Pub 2016. PMID: 27984655.
- Kim BJ, Tzeng CD, Cooper AB, Vauthey JN, Aloia TA. Borderline operability in hepatectomy patients is associated with higher rates of failure to rescue after severe complications. J Surg Oncol 115(3):337-343, 2017. e-Pub 2016. PMID: 27807846.
- Clarke CN, Patel SH, Day RW, George S, Sweeney C, Monetes De Oca GA, Aiss MA, Grubbs EG, Bednarski BK, Lee JE, Bodurka DC, Skibbber JM, Aloia TA. Implementation of a standardized electronic tool improves compliance, accuracy, and efficiency of trainee-to-trainee patient care handoffs after complex general surgical oncology procedures. Surgery 161(3):869-875, 2017. e-Pub 2016. PMID: 27825699.
- Cloyd JM, Tran Cao HS, Petzel MQ, Denbo JW, Parker NH, Nogueras-González GM, Liles JS, Kim MP, Lee JE, Vauthey JN, Aloia TA, Fleming JB, Katz MH. Impact of pancreatectomy on long-term patient-reported symptoms and quality of life in recurrence-free survivors of pancreatic and periampullary neoplasms. J Surg Oncol 115(2):144-150, 2017. e-Pub 2016. PMID: 27859270.
- Cloyd JM, Katz MH, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky BD, Lee JH, Bhutani MS, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PW, Evans DB, Lee JE. Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. J Gastrointest Surg 21(1):164-174, 2017. e-Pub 2016. PMID: 27778257.
- Prakash L, Bhosale P, Cloyd J, Kim M, Parker N, Yao J, Dasari A, Halperin D, Aloia TA, Lee JE, Vauthey JN, Fleming JB, Katz MH. Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors. J Gastrointest Surg 21(1):155-163, 2017. e-Pub 2016. PMID: 27634306.
- Denbo JW, Bruno ML, Cloyd JM, Prakash L, Lee JE, Kim M, Crane CH, Koay EJ, Krishnan S, Das P, Minsky BD, Varadhachary G, Shroff R, Wolff R, Javle M, Overman MJ, Fogelman D, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality. J Gastrointest Surg 20(12):1975-1985, 2016. e-Pub 2016. PMID: 27730398.
- Kim BJ, Aloia TA. An Inexpensive Modified Primary Closure Technique for Class IV (Dirty) Wounds Significantly Decreases Superficial and Deep Surgical Site Infection. J Gastrointest Surg 20(11):1904-1907, 2016. e-Pub 2016. PMID: 27142634.
- Ismael HN, Denbo J, Cox S, Crane CH, Das P, Krishnan S, Schroff RT, Javle M, Conrad C, Vauthey J, Aloia TA. Biologic mesh spacer placement facilitates safe delivery of dose-intense radiation therapy: A novel treatment option for unresectable liver tumors. Eur J Surg Oncol 42(10):1591-6, 2016. e-Pub 2016. PMID: 27296729.
- Odisio BC, Richter M, Aloia TA, Conrad C, Ahrar K, Gupta S, Vauthey JN, Huang SY. Use of prophylactic antibiotics to prevent abscess formation following hepatic ablation in patients with prior enterobiliary manipulation. J Gastrointest Surg 20(8):1428-34, 2016. e-Pub 2016. PMID: 26984694.
- Kim BJ, Caudle AS, Gottumukkala V, Aloia TA. The Impact of Postoperative Complications on a Timely Return to Intended Oncologic Therapy (RIOT): the Role of Enhanced Recovery in the Cancer Journey. Int Anesthesiol Clin 54(4):e33-46, 2016. PMID: 27623128.
- Shindoh J, de Aretxabala X, Aloia TA, Roa JC, Roa I, Zimmitti G, Javle M, Conrad C, Maru DM, Aoki T, Vigano L, Ribero D, Kokudo N, Capussotti L, Vauthey JN. Tumor Location Is a Strong Predictor of Tumor Progression and Survival in T2 Gallbladder Cancer: An International Multicenter Study. Ann Surg 261(4):733-9, 2015. e-Pub 2014. PMID: 24854451.
- Mise Y, Zimmitti G, Shindoh J, Kopetz S, Loyer EM, Andreou A, Cooper AB, Kaur H, Aloia TA, Maru DM, Vauthey JN. RAS Mutations Predict Radiologic and Pathologic Response in Patients Treated with Chemotherapy Before Resection of Colorectal Liver Metastases. Ann Surg Oncol 22(3):834-42, 2015. e-Pub 2014. PMID: 25227306.
- Mise Y, Mehran RJ, Aloia TA, Vauthey JN. Simultaneous lung resection via a transdiaphragmatic approach in patients undergoing liver resection for synchronous liver and lung metastases. Surgery 156(5):1197-203, 2014. e-Pub 2014. PMID: 24953274.
- Sheu T, Heymach JV, Swisher SG, Rao G, Weinberg JS, Mehran R, McAleer MF, Liao Z, Aloia TA, Gomez DR. Propensity Score-Matched Analysis of Comprehensive Local Therapy for Oligometastatic Non-Small Cell Lung Cancer That Did Not Progress After Front-Line Chemotherapy. Int J Radiat Oncol Biol Phys 90(4):850-7, 2014. e-Pub 2014. PMID: 25216859.
- Conrad C, Nedelcu M, Ogiso S, Aloia TA, Vauthey JN, Gayet B. Laparoscopic Intragastric Surgery for Early Gastric Cancer and Gastrointestinal Stromal Tumors. Ann Surg Oncol 21(8):2620, 2014. e-Pub 2014. PMID: 24647675.
- Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S, Vauthey JN. Return to intended oncologic treatment (RIOT): A novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol 110(2):107-14, 2014. e-Pub 2014. PMID: 24846705.
- Thomas RM, Aloia TA, Truty MJ, Tseng WH, Choi EA, Curley SA, Vauthey JN, Abdalla EK. Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma. HPB (Oxford) 16(7):677-85, 2014. e-Pub 2013. PMID: 24308564.
- Aloia TA, Cooper A, Shi W, Vauthey JN, Lee JE. Reoperative Surgery: A Critical Risk Factor for Complications Inadequately Captured by Operative Reporting and Coding of Lysis of Adhesions. J Am Coll Surg 219(1):143-50, 2014. e-Pub 2014. PMID: 24862888.
- Cooper AB, Holmes HM, des Bordes JK, Fogelman D, Parker NH, Lee JE, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Role of Neoadjuvant Therapy in the Multimodality Treatment of Older Patients with Pancreatic Cancer. J Am Coll Surg 219(1):111-20, 2014. e-Pub 2014. PMID: 24856952.
- Tzeng CW, Balachandran A, Ahmad M, Lee JE, Krishnan S, Wang H, Crane CH, Wolff RA, Varadhachary GR, Pisters PW, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. HPB (Oxford) 16(5):430-8, 2014. e-Pub 2013. PMID: 23991810.
- Tzeng CW, Cooper AB, Vauthey JN, Curley SA, Aloia TA. Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB (Oxford) 16(5):459-68, 2014. e-Pub 2013. PMID: 24033514.
- Yoon SS, Aloia TA, Haynes AB, Kambadakone A, Kaur H, Vauthey JN, Ferrone CR, Zhu AX, Wo JY, Crane C, Hong TS. Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapy. Pract Radiat Oncol 4(3):167-73, 2014. e-Pub 2013. PMID: 24766683.
- Tzeng CW, Katz MH, Lee JE, Fleming JB, Pisters PW, Vauthey JN, Aloia TA. Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13 771 NSQIP patients. HPB (Oxford) 16(4):373-83, 2014. e-Pub 2013. PMID: 23869628.
- Javle M, Rashid A, Churi C, Kar S, Zuo M, Eterovic AK, Nogueras-Gonzalez GM, Janku F, Shroff RT, Aloia TA, Vauthey JN, Curley S, Mills G, Roa I. Molecular Characterization of Gallbladder Cancer using Somatic Mutation Profiling. Hum Pathol 45(4):701-8, 2014. e-Pub 2013. PMID: 24508317.
- Huang SY, Aloia TA, Shindoh J, Ensor J, Shaw CM, Loyer EM, Vauthey JN, Wallace MJ. Efficacy and Safety of Portal Vein Embolization for Two-Stage Hepatectomy in Patients with Colorectal Liver Metastasis. J Vasc Interv Radiol 25(4):608-17, 2014. e-Pub 2013. PMID: 24315549.
- Raoof M, Aloia TA, Vauthey JN, Curley SA. Morbidity and Mortality in 1,174 Patients Undergoing Hepatic Parenchymal Transection Using a Stapler Device. Ann Surg Oncol 21(3):995-1001, 2014. e-Pub 2013. PMID: 24248530.
- Tzeng CW, Katz MH, Fleming JB, Lee JE, Pisters PW, Holmes HM, Varadhachary GR, Wolff RA, Abbruzzese JL, Vauthey JN, Aloia TA. Morbidity and Mortality after Pancreaticoduodenectomy in Patients with Borderline Resectable Type C Clinical Classification. J Gastrointest Surg 18(1):146-55; discussion 155-6, 2014. e-Pub 2013. PMID: 24129825.
- Tzeng CW, Tran Cao HS, Lee JE, Pisters PW, Varadhachary GR, Wolff RA, Abbruzzese JL, Crane CH, Evans DB, Wang H, Abbott DE, Vauthey JN, Aloia TA, Fleming JB, Katz MH. Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival. J Gastrointest Surg 18(1):16-24; discussion 24-5, 2014. e-Pub 2013. PMID: 24241967.
- Shindoh J, Tzeng CW, Aloia TA, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN. Safety and Efficacy of Portal Vein Embolization Before Planned Major or Extended Hepatectomy: An Institutional Experience of 358 Patients. J Gastrointest Surg 18(1):45-51, 2014. e-Pub 2013. PMID: 24129824.
- Kaseb AO, Shah NN, Hassabo HM, Morris JS, Xiao L, Abaza YM, Soliman K, Lee JS, Vauthey JN, Wallace M, Aloia TA, Curley S, Abbruzzese JL, Hassan MM. Reassessing hepatocellular carcinoma staging in a changing patient population. Oncology 86(2):63-71, 2014. e-Pub 2014. PMID: 24401634.
- Kaseb AO, Xiao L, Hassan MM, Chae YK, Lee JS, Vauthey JN, Krishnan S, Cheung S, Hassabo HM, Aloia TA, Conrad C, Curley SA, Vierling JM, Jalal P, Raghav K, Wallace M, Rashid A, Abbruzzese JL, Wolff RA, Morris JS. Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular Carcinoma. J Natl Cancer Inst 106(5), 2014. e-Pub 2014. PMID: 24815863.
- Zimmitti G, Vauthey JN, Shindoh J, Tzeng CW, Roses RE, Ribero D, Capussotti L, Giuliante F, Nuzzo G, Aloia TA. Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications. J Am Coll Surg 217(6):1028-37, 2013. PMID: 24246619.
- Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Gupta S, Wallace MJ, Vauthey JN. Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival. Br J Surg 100(13):1777-83, 2013. PMID: 24227364.
- Cooper AB, Habra MA, Grubbs EG, Bednarski BK, Ying AK, Perrier ND, Lee JE, Aloia TA. Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma?. Surg Endosc 27(11):4026-32, 2013. e-Pub 2013. PMID: 23765427.
- Das P, Abboud MT, Haque W, Javle M, Kaseb A, Curley SA, Vauthey JN, Aloia TA, Beddar AS, Delclos ME, Krishnan S, Crane CH. Gastric Bleeding After Radiation Therapy for Intrahepatic Cholangiocarcinoma. Pract Radiat Oncol 3(4):344-8, 2013. e-Pub 2012. PMID: 24674408.
- Tzeng CW, Curley SA, Vauthey JN, Aloia TA. Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients. HPB (Oxford) 15(10):773-80, 2013. e-Pub 2013. PMID: 23869577.
- Vauthey JN, Zimmitti G, Kopetz SE, Shindoh J, Chen SS, Andreou A, Curley SA, Aloia TA, Maru DM. RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases. Ann Surg 258(4):619-27, 2013. PMID: 24018645.
- Peungjesada S, Aloia TA, Kaur H, Marcal L, Choi H, Vauthey JN, Loyer EM. Intrabiliary growth of colorectal liver metastasis: spectrum of imaging findings and implications for surgical management. AJR Am J Roentgenol 201(4):W582-9, 2013. PMID: 24059396.
- Kaseb AO, Shindoh J, Patt YZ, Roses RE, Zimmitti G, Lozano RD, Hassan MM, Hassabo HM, Curley SA, Aloia TA, Abbruzzese JL, Vauthey JN. Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma. Cancer 119(18):3334-42, 2013. e-Pub 2013. PMID: 23821538.
- Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN. Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol 20(8):2493-500, 2013. e-Pub 2013. PMID: 23377564.
- Gaber AO, Moore LW, Aloia TA, Suki WN, Jones SL, Graviss EA, Knight RJ, Bass BL. Cross-sectional and Case-Control Analyses of the Association of Kidney Function Staging With Adverse Postoperative Outcomes in General and Vascular Surgery. Ann Surg 258(1):169-77, 2013. e-Pub 2013. PMID: 23478526.
- Shindoh J, Vauthey JN, Zimmitti G, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Aloia TA. Analysis of the Efficacy of Portal Vein Embolization for Patients with Extensive Liver Malignancy and Very Low Future Liver Remnant Volume, Including a Comparison with the Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy Approach. J Am Coll Surg 217(1):126-33; discussion 133-4, 2013. e-Pub 2013. PMID: 23632095.
- Frenette CT, Boktour M, Burroughs SG, Kaseb A, Aloia TA, Galati J, Gaber AO, Monsour H, Ghobrial RM. Pre-Transplant Utilization of Sorafenib is Not Associated with Increased Complications after Liver Transplantation. Transpl Int 26(7):734-9, 2013. e-Pub 2013. PMID: 23701126.
- Landry CS, Lin HY, Phan A, Charnsangavej C, Abdalla EK, Aloia TA, Nicolas Vauthey J, Katz MH, Yao JC, Fleming JB. Resection of at-risk mesenteric lymph nodes is associated with improved survival in patients with small bowel neuroendocrine tumors. World J Surg 37(7):1695-700, 2013. PMID: 23657749.
- Andreou A, Aloia TA, Brouquet A, Dickson PV, Zimmitti G, Maru DM, Kopetz S, Loyer EM, Curley SA, Abdalla EK, Vauthey JN. Margin Status Remains an Important Determinant of Survival after Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy. Ann Surg 257(6):1079-88, 2013. e-Pub 2013. PMID: 23426338.
- Shindoh J, Andreou A, Aloia TA, Zimmitti G, Lauwers GY, Laurent A, Nagorney DM, Belghiti J, Cherqui D, Poon RT, Kokudo N, Vauthey JN. Microvascular Invasion Does Not Predict Long-Term Survival in Hepatocellular Carcinoma up to 2 cm: Reappraisal of the Staging System for Solitary Tumors. Ann Surg Oncol 20(4):1223-9, 2013. e-Pub 2012. PMID: 23179993.
- Badgwell BD, Aloia TA, Garrett J, Chedister G, Miner T, Krouse R. Indicators of symptom improvement and survival in in patients with advanced cancer undergoing palliative surgical consultation. J Surg Oncol 107(4):367-71, 2013. e-Pub 2012. PMID: 22886727.
- Tzeng CW, Aloia TA, Vauthey JN, Chang GJ, Ellis LM, Feig BW, Curley SA, Skibber JM, Abdalla EK, You YN, Rodriguez-Bigas MA. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: A matched case-control cnalysis. Ann Surg Oncol 20(2):482-90, 2013. e-Pub 2012. PMID: 22932858.
- Shindoh J, Truty MJ, Aloia TA, Curley SA, Zimmitti G, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN. Kinetic Growth Rate after Portal Vein Embolization Predicts Posthepatectomy Outcomes: Toward Zero Liver-Related Mortality in Patients with Colorectal Liver Metastases and Small Future Liver Remnant. JACS 216(2):201-9, 2013. e-Pub 2012. PMID: 23219349.
- Andreou A, Vauthey JN, Cherqui D, Zimmitti G, Ribero D, Truty MJ, Wei SH, Curley SA, Laurent A, Poon RT, Belghiti J, Nagorney DM, Aloia TA, International Cooperative Study Group on Hepatocellular Carcinoma. Improved Long-Term Survival after Major Resection for Hepatocellular Carcinoma: A Multicenter Analysis Based on a New Definition of Major Hepatectomy. J Gastrointest Surg 17(1):66-77, 2013. e-Pub 2012. PMID: 22948836.
- Zimmitti G, Roses RE, Andreou A, Shindoh J, Curley SA, Aloia TA, Vauthey JN. Greater Complexity of Liver Surgery is Not Associated with an Increased Incidence of Liver-Related Complications Except for Bile Leak: An Experience with 2,628 Consecutive Resections. J Gastrointest Surg 17(1):57-64; discussion p.64-5, 2013. e-Pub 2012. PMID: 22956403.
- Kaseb AO, Shama M, Sahin IH, Nooka A, Hassabo HM, Vauthey JN, Aloia TA, Abbruzzese JL, Subbiah IM, Janku F, Curley S, Hassan MM. Prognostic Indicators and Treatment Outcome in 94 Cases of Fibrolamellar Hepatocellular Carcinoma. Oncology 85(4):197-203, 2013. e-Pub 2013. PMID: 24051705.
- Shindoh J, Loyer EM, Kopetz S, Boonsirikamchai P, Maru DM, Chun YS, Zimmitti G, Curley SA, Charnsangavej C, Aloia TA, Vauthey JN. Optimal Morphologic Response to Preoperative Chemotherapy: An Alternate Outcome End Point before Resection of Hepatic Colorectal Metastases. J Clin Oncol 30(36):4566-72, 2012. e-Pub 2012. PMID: 23150701.
- Vauthey JN, Kopetz S, Aloia TA, Andreou A. KRAS mutation in colorectal cancer metastases after adjuvant FOLFOX for the primary. Br J Cancer 107(8):1442-3; author reply 1444, 2012. e-Pub 2012. PMID: 23018559.
- Andreou A, Kopetz S, Maru DM, Chen SS, Zimmitti G, Brouquet A, Shindoh J, Curley SA, Garrett C, Overman MJ, Aloia TA, Vauthey JN. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases. Ann Surg 256(4):642-50, 2012. PMID: 22968062.
- Abbott DE, Cantor SB, Hu CY, Aloia TA, You YN, Nguyen S, Chang GJ. Optimizing clinical and economic outcomes of surgical therapy for patients with colorectal cancer and synchronous liver metastases. J Am Coll Surg 215(2):262-70, 2012. e-Pub 2012. PMID: 22560316.
- Tzeng CW, Katz MH, Fleming JB, Pisters PW, Lee JE, Abdalla EK, Curley SA, Vauthey JN, Aloia TA. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford) 14(8):506-13, 2012. e-Pub 2012. PMID: 22762398.
- Andreou A, Brouquet A, Abdalla EK, Aloia TA, Curley SA, Vauthey JN. Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB (Oxford) 13(11):774-82, 2011. e-Pub 2011. PMID: 21999590.
- Kaseb AO, Morris JS, Hassan MM, Siddiqui AM, Lin E, Xiao L, Abdalla EK, Vauthey JN, Aloia TA, Krishnan S, Abbruzzese JL. Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma. J Clin Oncol 29(29):3892-9, 2011. e-Pub 2011. PMID: 21911725.
- Kaseb AO, Abbruzzese JL, Vauthey JN, Aloia TA, Abdalla EK, Hassan MM, Lin E, Xiao L, El-Deeb AS, Rashid A, Morris JS. I-CLIP: Improved Stratification of Advanced Hepatocellular Carcinoma Patients by Integrating Plasma IGF-1 into CLIP Score. Oncology 80(5-6):373-81, 2011. e-Pub 2011. PMID: 21822028.
- Aloia TA, Knight R, Gaber AO, Ghobrial RM, Goss JA. Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple model for end-stage liver disease-independent prognostic factors. Liver Transpl 16(8):950-9, 2010. PMID: 20589647.
- Aloia TA, McFadden DW. Candida in pancreatic infection: a clinical experience. The American Surgeon 60:793-96, 1994.
- Spinks T, Albright HW, Feeley TW, Walters R, Burke TW, Aloia TA, Bruera E, Buzdar A, Foxhall L, Hui D, Summers B, Rodriguez A, Dubois R, Shine KI. Ensuring quality cancer care: A follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in America. Cancer. e-Pub 2011. PMID: 22045610.
- Andreou A, Brouquet A, Bharathy KG, Perrier ND, Abdalla EK, Curley SA, Glanemann M, Seehofer D, Neuhaus P, Vauthey JN, Aloia TA. Liver resection for liver metastases from nondigestive endocrine cancer: extrahepatic disease burden defines outcome. Surgery. e-Pub 2012. PMID: 22306838.
- Gaber OA, Moore LW, Aloia TA, Suki W, Jones SL, Knight RJ, Bass BL. Change in Glomerular Filtration Rate as a Predictor of Surgical Outcomes. Annals of Surgery.
- Aloia TA. Validation of a modified Child-Pugh score ofr predicitin survival in patients with hepatocellular carcinoma.
- Cho SW, Tzeng CW, Johnston WC, Cassera MA, Newell PH, Hammill CW, Wolf RF, Aloia TA, Hansen PD. Neoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). HPB (Oxford). e-Pub 2013. PMID: 24112766.
- Mahajan SN, Ariza-Heredia EJ, Rolston KV, Graviss LS, Feig BW, Aloia TA, Chemaly RF. Perioperative Antimicrobial Prophylaxis for Intra-abdominal Surgery in Patients with Cancer: A Retrospective Study Comparing Ertapenem and Nonertapenem Antibiotics. Ann Surg Oncol. e-Pub 2013. PMID: 24114052.
- Short MN, Aloia TA, Ho V. The influence of complications on the costs of complex cancer surgery. Cancer. e-Pub 2013. PMID: 24382697.
- Tran Cao HS, Balachandran A, Wang H, Nogueras-González GM, Bailey CE, Lee JE, Pisters PW, Evans DB, Varadhachary G, Crane CH, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Radiographic Tumor-Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer. J Gastrointest Surg. e-Pub 2013. PMID: 24129826.
- Conrad C, Nedelcu M, Ogiso S, Aloia TA, Vauthey JN, Gayet B. Techniques of intragastric laparoscopic surgery. Surg Endosc. e-Pub 2014. PMID: 25106714.
- Schwarz L, Fleming J, Katz M, Lee J, Aloia TA, Vauthey N, Conrad C. Total Laparoscopic Central Pancreatectomy with Pancreaticogastrostomy for High Risk Cystic Neoplasm. Ann Surg Oncol. e-Pub 2016. PMID: 26542586.
- Odisio BC, Yamashita S, Frota L, Huang SY, Kopetz SE, Ahrar K, Chun YS, Aloia TA, Hicks ME, Gupta S, Vauthey JN. Planned Treatment of Advanced Metastatic Disease with Completion Ablation After Hepatic Resection. J Gastrointest Surg. e-Pub 2016. PMID: 27882510.
Invited Articles
- Aloia TA. Extending the Limits of Resection for Colorectal Liver Metastases: Bilateral Disease. J Gastrointest Surg 21(1):193-195, 2017. e-Pub 2016. PMID: 27649705.
- Kim BJ, Aloia TA. Cost-Effectiveness of Palliative Surgery versus Nonsurgical Procedures in Gastrointestinal Cancer Patients. J Surg Oncol 114(3):316-22, 2016. e-Pub 2016. PMID: 27132654.
- Aloia TA. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy: Portal Vein Embolization Should Remain the Gold Standard. JAMA Surg 150(10):927-8, 2015. e-Pub 2015. PMID: 26308668.
- Aloia TA. Insights into ALPPS. Eur J Surg Oncol 41(5):610-1, 2015. e-Pub 2015. PMID: 25716333.
- Ganai S, Thirunavukarasu P, Aloia TA, Choti MA. Timing of Therapies for Patients with Resectable Hepatic Colorectal Metastases. ASCO Connection, 2015.
- Buell J, Geller D, Asbun H, Aloia TA, Tsung A, Jarnagin W. On the Spot: Developments in Approaches to Liver Resection. General Surgery News 41(09):2-11, 2014.
- Tzeng CW, Aloia TA. Colorectal Liver Metastases. J Gastrointest Surg 17(1):195-202, 2013. e-Pub 2012. PMID: 23054896.
- Andreou A, Aloia TA, Brouquet A, Vauthey JN. Recent advances in the curative treatment of colorectal liver metastases. Gastrointest Cancer Res 4(4 Suppl 1):S2-8, 2011. PMID: 22368730.
- Aloia TA, Fahy BN. Chemotherapy-associated hepatotoxicity: How concerned should we be?. Expert Rev Anticancer Ther 10(4):521-27, 2010. PMID: 20397917.
- Aloia TA, Fahy BN. Chemotherapy-associated liver injury: Does it really matter?. Current Colorectal Cancer Reports 5:108-13, 2009.
- Aloia TA, Adam R, Azoulay D, Bismuth H, Castaing D. Long-term Results of Hepatic Resection Following, Conversion of Initially Unresectable Colorectal Metastases with Systemic Chemotherapy. Current Colorectal Cancer Reports 2, 2006.
- Aloia TA, Adam R, Abdalla EK, Azoulay D, Curley S, Vauthey JN, Castaing D. Evidence for Resection of Colorectal Cancer. Current Colorectal Cancer Reports 2, 2006.
- Cooper AB, Aloia TA. Managing Disappearing Liver Metastases Following Chemotherapy. Current Colorectal Cancer Reports. e-Pub 2014.
- Aloia, TA. Is PVE vs. ALPPS Debatable?. JAMA Surgery.
Manuals, Teaching Aids, Other Teaching Publications
- Cooper AB, Habra MA, Grubbs EG, Bednarski BK, Ying AK, Perrier ND, Lee JE, Aloia TA. Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma?. Learning Management System: SAGES University, 2014.
- Aloia TA. Surgical Oncology Ultrasound Training Curriculum, The University of Texas MD Anderson Cancer Center, 2013.
- Aloia TA. Complications in General Surgery In: Pocket Surgery. Lippincott, Williams and Wilkins, Inc: Philadelphia, 2002.
Other Articles
- Aloia TA Contemplation versus Documentation Before Surgery. Ann Surg 259(6):1038-40, 2014. PMID: 24646563.
- Adams RB, Aloia TA, Loyer E, Pawlik TM, Taouli B, Vauthey JN Selection for Hepatic Resection of Colorectal Liver Metastases: Expert Consensus Statement. HPB (Oxford) 15(2):91-103, 2013. PMID: 23297719.
- Schwarz RE, Abdalla EK, Aloia TA, Vauthey JN AHPBA/SSO/SSAT sponsored consensus conference on the multidisciplinary treatment of colorectal cancer metastases. HPB (Oxford) 15(2):89-90, 2013. PMID: 23297718.
- Aloia TA, Hemming A, Schwartz M Surgical treatment of hepatocellular cancer: expert consensus conference. HPB (Oxford) 12(5):311-12, 2010. PMID: 20590904.
Editorials
- Aloia TA. Adjuvant Surgery for Breast Cancer Liver Metastases. Commentary on "Liver resection and local ablation of breast cancer liver metastases-A systematic review". Breast Diseases: A Year Book Quarterly 23(2):169-171, 2012.
- Aloia TA, Vauthey JN. Management of colorectal liver metastases: past, present, and future. Updates Surg 63(1):1-3, 2011. PMID: 21331669.
- Aloia TA. Predicting adverse outcomes after complex cancer surgery. Ann Surg Oncol 17(9):2260-1, 2010. PMID: 20585873.
- Aloia TA. Curative therapy for HCC: No one size (modality) fits all. [Editorial to Jarnagin W, Chapman WC, Curley SA, D'Angelica M, Dixon E, Rosen C, et al. Surgical Treatment of Hepatocellular Carcinoma: Expert Consensus Statement]. HPB, 2010.
- Aloia TA. Predicting outcome in complex cancer surgery. [Editorial to Al-Rafaie, Waddah, et al. Assessment of ACS NSQIP's Predictive Ability for Adverse Events after Major Cancer Surgery. Ann Surg Oncol 17:2274-82, 2010]. Ann Sug Oncol 17:2260-61, 2010.
- Aloia TA, Lee JE, Vauthey JN, Abdalla EK, Wolfe RA, Crane RH, Evans DB, Pisters PWT. Continuing Medical Education (CME) Featured Article: Impact of prolonged recovery after pancreaticoduodenectomy on delivery of adjuvant therapy to patients with pancreatic adenocarcinoma. J Am Coll Surg 204:522-3, 2007.
Book Chapters
- Shindoh J, Madoff DC, Aloia TA, Vauthey JN. Preoperative Portal Vein Embolization: Technique and Results. In: Blumgart's Surgery of the Liver, Biliary Tract, and Pancreas. 6th Edition Elsevier, 2016.
- Thirunavukarasu P, Aloia TA. Preoperative assessment and optimization of the future liver remnant. In: Surg Clin North Am. 2, 197-205, 2016.
- Aloia TA, Vauthey JN. Hepatic Metastasis from Colorectal Cancer. In: Blumgart’s Surgery of the Liver, Biliary Tract, and Pancreas. 6th Edition Elsevier, 2016.
- Day R and Aloia TA. Preoperative considerations for major hepatectomy. In: Patologia Del Higado, Via Bilar Y Pancreas, Principios y Practica, 2015.
- Aloia TA, Day R. Managing Early and Late Postoperative Complications following Gastric Surgery. In: Gastric Cancer Principles and Practice, 2015.
- Aloia TA. Benign Liver Tumors. In: Clinical Decision Support System on Surgery, 2015.
- Aloia TA. Indications and Contraindications to laparoscopic liver surgery. In: Laparoscopic Liver, Pancreas, Biliary Surgery: Textbook and Atlas, 2014.
- Fuks D, Aloia TA, Gayet B. Enhanced Recovery After HPB Surgery. In: Laparoscopic Management of Hepato-Pancreato-Biliary (HPB) Diseases, 2014.
- Tzeng CW, Aloia TA. Complications of Liver Surgery Including Hepatic Insufficiency. In: The Handbook of Hepatobiliary and Pancreatic Surgery, 2013.
- Cooper AB, AloiaTA, Vauthey JN, Curley SA. Controversies in Advanced Disease-Surgical Approcaches for Metastatic Resection. In: Surgical Treatment of Colorectal Liver Mets, 2013.
- Aloia TA, Gaber OA, Ghobrial RM. Liver Transplant for Hepatocellular Carcinoma. In: Hepatocellular Carcinoma, 219-238, 2011.
- Aloia TA. Non-Colorectal Gastrointestinal Liver Metastases. In: Liver Metastases, 169-178, 2009.
- Vauthey JN, Pawlik TM, Abdalla EK, Aloia TA. Intrahepatic Bile Duct Cancer Staging. In: AJCC Cancer Staging Manual. 7th, 201-210, 2009.
- Adam R, Miller R, Pitombo M, Wicherts DA, de Haas RJ, Bitsakou G, Aloia TA. Two Stage Hepatectomy Approach for Initially Unresectable Colorectal Hepatic Metastases. In: Surg Oncol Clin N Am. 3, 525-36, viii, 2007.
- Aloia TA, Crane OH, Vauthey JN. Gallbladder Carcinoma. In: Textbook of Hepatology: From Basic Science to Clinical Practice. 3rd, 1575-1582, 2006.
- Aloia TA, Gershenwald JE. Management of Early-Stage Cutaneous Melanoma. In: Current Problems in Surgery, 455-534, 2004.
- Aloia TA, Harpole DW. Embryology of the Lung. In: General Thoracic Surgery. 6th. Lippincott, Williams, and Wilkins, Inc: Philadelphia, 16-28, 2003.
- Aloia TA, Harpole DW. Embryology of the Lung. In: General Thoracic Surgery. 5th. Lippincott, Williams, and Wilkins: Philadelphia, 15-26, 1999.
- Ismael H, Aloia TA. Management of Testicular Cancer Liver Metastases. In: Noncolorectal Non-Neuroendocrine Liver Tumors. Springer.
- You YN, Eng C, Aloia TA. Multidisciplinary Management of Stage IV Disease. In: Seminars in Colon and Rectal Surgery: Colon Cancer Issue.
- Aloia TA. Minimally Invasive Liver Surgery: Indications and Contraindications. In: Laparoscopic Liver, Pancreas and Biliary Surgery: Textbook and Illustrated Video Atlas.
Letters to the Editor
- Aloia TA, Gottumukkala V. Reply: Transfusion reduction in liver surgery is a team sport. Surgery 160: 248, 2016.
- Aloia TA, Vauthey JN. Reply: Air Leak Test, Two Hands Are Better Than None. J Am Coll Surg 218: 1078-9, 2014.
- Aloia TA, Vauthey JN. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS): What is Gained and What is Lost?. Ann Surg 256: e9; author reply e16-9, 2012.
